Cathelicidin LL-37 Levels in the GCF and the Saliva of Smokers and Non-smokers With Stage III,IV Periodontitis
CompletedOBSERVATIONAL
Enrollment
60
Participants
Timeline
Start Date
February 23, 2021
Primary Completion Date
February 23, 2021
Study Completion Date
April 15, 2021
Conditions
Smoking Reduction
Trial Locations (1)
11562
Faculty of dentistry cairo university, Al Manyal
All Listed Sponsors
lead
Cairo University
OTHER
NCT04861493 - Cathelicidin LL-37 Levels in the GCF and the Saliva of Smokers and Non-smokers With Stage III,IV Periodontitis | Biotech Hunter | Biotech Hunter